About 1 in 100 people worldwide have celiac disease, though the exact number depends on how you measure it. A large meta-analysis of nearly 276,000 people found that 1.4% tested positive on blood screening, while 0.7% had the diagnosis confirmed by intestinal biopsy. In the United States, roughly 2 million people are estimated to have the condition. The gap between blood-test prevalence and biopsy-confirmed cases hints at something important: a huge number of people with celiac disease don’t know they have it.
Most Cases Go Undiagnosed
More than 80% of people with celiac disease have never been formally diagnosed. That means for every person managing the condition with a gluten-free diet, there are roughly four others still eating gluten and potentially damaging their small intestine without realizing it. Some have mild or no obvious digestive symptoms, which makes the condition easy to miss. Others have symptoms that get attributed to irritable bowel syndrome, stress, or general fatigue.
This diagnostic gap is why the blood-screening number (1.4%) runs so much higher than the biopsy-confirmed number (0.7%). Many people picked up by screening in research studies had never been tested in real life. Whether mass screening of the general population makes sense is still debated, but the size of the undiagnosed group is striking.
Rates Vary Widely by Country
Celiac disease is not evenly distributed around the world. Finland has one of the highest reported rates at about 2%, while Italy sits around 1.2% and Germany comes in lower at 0.3%. Saudi Arabia has reported rates as high as 3.2% in some studies, while Tunisia and Egypt fall well below 1%. In Switzerland, roughly 1 in 132 people have the condition, compared to 1 in 1,000 or even 1 in 2,000 in some other European countries.
These differences reflect a mix of genetics, diet patterns, and how aggressively each country screens for the disease. Populations with higher rates of the genetic markers linked to celiac disease tend to have more cases, but environmental factors like infant feeding practices and overall wheat consumption also play a role.
The Disease Is Becoming More Common
Celiac disease isn’t just being detected more often. It’s genuinely increasing. A systematic review of incidence trends found that new cases have been rising by about 7.5% per year over recent decades, a pattern that holds across the Western world from the second half of the 20th century into the 21st. Better awareness and more testing explain part of this rise, but studies comparing old and new blood samples from the same populations confirm that the underlying rate of the disease itself is climbing. Changes in wheat varieties, shifts in gut bacteria, and differences in how and when gluten gets introduced to infants are all plausible contributors, though no single explanation has been pinned down.
Women Are Diagnosed More Often Than Men
Diagnosed celiac disease skews heavily female. In population-based studies, women outnumber men roughly 2 to 1, and some clinical cohorts report ratios as high as 10 to 1. Women also tend to be diagnosed younger, around age 44 on average compared to nearly 49 for men. This doesn’t necessarily mean celiac disease is rarer in men. It may be that men are less likely to seek care for digestive symptoms or that their symptoms present differently, leading to fewer diagnoses.
One notable finding: once diagnosed, men with celiac disease appear to have lower age-adjusted survival than women, though this gap mirrors the survival difference between men and women in the general population. Autoimmune conditions that commonly co-occur with celiac disease, like thyroid disorders, affect men and women with celiac disease at roughly equal rates (about 31-32%).
Family Members Face Much Higher Risk
If someone in your immediate family has celiac disease, your odds jump dramatically. About 1 in 14 first-degree relatives (parents, siblings, children) of a celiac patient also have the condition, confirmed by biopsy. That’s roughly 7%, compared to under 1% in the general population.
The risk isn’t equal across all family members. Daughters of someone with celiac disease have the highest rates, with about 1 in 4 affected. Sisters come next at roughly 1 in 7, followed by brothers at 1 in 11 and sons at 1 in 16. Parents of a celiac patient have about a 1 in 20 chance. These numbers are high enough that screening first-degree relatives is widely recommended, even if they have no symptoms.
The genetic component is straightforward. Two specific immune system gene variants are required to develop celiac disease. About 18-30% of the general population carries one or both of these variants, but only a small fraction of carriers ever develop the disease. Among first-degree relatives of celiac patients, 40-65% carry the relevant genes, which partly explains their elevated risk.
People With Type 1 Diabetes Are Especially Affected
Certain autoimmune conditions significantly increase the likelihood of celiac disease. Type 1 diabetes stands out: approximately 1 in 16 people with type 1 diabetes worldwide also has celiac disease, and in Asia and the Middle East the ratio is closer to 1 in 12. A meta-analysis found that 6% of type 1 diabetes patients have biopsy-confirmed celiac disease, with 9% testing positive on blood screening. Because both conditions share genetic risk factors and because untreated celiac disease can make blood sugar harder to control, screening is standard practice for people with type 1 diabetes.
Other conditions that overlap with celiac disease at higher-than-average rates include autoimmune thyroid disease, Down syndrome, Turner syndrome, and selective IgA deficiency (a common immune system variation that, ironically, can also cause false negatives on standard celiac blood tests).